Technology | Computed Tomography (CT) | October 06, 2016

MedicVision Highlighting SafeCT-29 Solution at RSNA 2016

CT dose optimization product line also includes SafeCT Enterprise and SafeCT Dose Reporting

Medic Vision, SafeCT-29, RSNA 2016, SafeCT Enterprise, SafeCT Dose Reporting

October 6, 2016 — Medic Vision is exhibiting at the 2016 Annual Meeting of the Radiological Society of North America (RSNA 2016) and will be highlighting its SafeCT-29 product.

The SafeCT product line enhances computed tomography (CT) images acquired with low-dose protocols. SafeCT-29 is the only U.S. Food and Drug Administration (FDA)-approved third-party solution that offers XR-29 functionality to help achieve Smart Dose Compliance, according to Medic Vision.

The SafeCT product line also includes SafeCT Enterprise and SafeCT Dose Reporting.

The SafeCT-29 product was recently endorsed by Philips Healthcare as a solution for customers that have computed tomography (CT) and positron emission tomography (PET)/CT scanners that are not fully compliant with XR-29 standards and for which Philips does not offer an XR-29 update.

For more information: www.medicvision.com

Related Content

In a study of more than 1,000 patients published in the journal Radiology, chest CT outperformed lab testing in the diagnosis of 2019 novel coronavirus disease (COVID-19) #COVID19 #COVID-2019 #2019nCoV

Chest CT images of a 29-year-old man with fever for 6 days. RT-PCR assay for the SARS-CoV-2 using a swab sample was performed on Feb. 5, 2020, with a positive result. (A column) Normal chest CT with axial and coronal planes was obtained at the onset. (B column) Chest CT with axial and coronal planes shows minimal ground-glass opacities in the bilateral lower lung lobes (yellow arrows). (C column) Chest CT with axial and coronal planes shows increased ground-glass opacities (yellow arrowheads). (D column) Chest CT with axial and coronal planes shows the progression of pneumonia with mixed ground-glass opacities and linear opacities in the subpleural area. (E column) Chest CT with axial and coronal planes shows the absorption of both ground-glass opacities and organizing pneumonia. Image courtesy of Radiology

News | Computed Tomography (CT) | February 26, 2020 | Melinda Taschetta-Millane and Dave Fornell
February 26, 2020 — In a study of m
 over the course of a week and a half #coronavirus #COVID19 #COVID-2019 #2019nCoV

29-year old male with unknown exposure history, presenting with fever and cough, ultimately requiring intensive care unit admission. (a) Axial thin-section non-contrast CT scan shows diffuse bilateral confluent and patchy ground-glass (solid arrows) and consolidative (dashed arrows) pulmonary opacities. (b) The disease in the right middle and lower lobes has a striking peripheral distribution (arrow). Image courtesy of Radiology 

News | Computed Tomography (CT) | February 26, 2020
February 26, 2020 — Mount Sinai Health System physicians—the
Images in a 41-year-old woman who presented with fever and positive polymerase chain reaction assay for the 2019 novel coronavirus (2019-nCoV) #coronavirus #nCoV2019 #2019nCoV #COVID19

Images in a 41-year-old woman who presented with fever and positive polymerase chain reaction assay for the 2019 novel coronavirus (2019-nCoV). Three representative axial thin-section chest CT images show multifocal ground glass opacities without consolidation. Three-dimensional volume-rendered reconstruction shows the distribution of the ground-glass opacities (arrows). Image courtesy of the Radiological Society of North America (RSNA)

News | Radiology Imaging | February 25, 2020
February 24, 2020 — The U.S.
Carestream’s state-of-the-art OnSight 3D Extremity System
News | Computed Tomography (CT) | February 25, 2020
February 25, 2020 — Carestream’s state-of-the-art...
An axial CT image obtained without intravenous contrast in a 36‐year‐old male (Panel A) shows bilateral ground‐glass opacities in the upper lobes with a rounded morphology (arrows). #coronavirus #nCoV2019 #2019nCoV #COVID19

An axial CT image obtained without intravenous contrast in a 36‐year‐old male (Panel A) shows bilateral ground‐glass opacities in the upper lobes with a rounded morphology (arrows). Image courtesy of Radiology Online.

News | Computed Tomography (CT) | February 20, 2020
February 20, 2020 — In new research
Chest CT imaging of patient. #coronavirus #nCoV2019 #2019nCoV #COVID19

Examples of typical chest CT findings compatible with COVID-19 pneumonia in patients with epidemiological and clinical presentation suspicious for COVID-19 infection. This image is part of the original research, Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR, published Feb. 19, 2020, in Radiology Online.

News | Computed Tomography (CT) | February 19, 2020
February 19, 2020 — In new research
Potassium Molybdate Mo 99 Source Vessels for RadioGenix System

Potassium Molybdate Mo 99 Source Vessels for RadioGenix System (Photo: Business Wire)

News | Radiopharmaceuticals and Tracers | February 18, 2020
February 18, 2020 — NorthStar Medical Radioisotopes, LLC, a
Novel Coronavirus 2019-nCoV Pneumonia. #coronavirus #nCoV2019 #2019nCoV #COVID19

Image by _freakwave_ from Pixabay 

News | Computed Tomography (CT) | February 16, 2020
February 16, 2020 — The following statement was issued by the U.S.
negative RT-PCR results and chest CT findings compatible with 2019-nCoV pneumonia. #coronavirus #nCoV2019 #2019nCoV #COVID19

Figure 1: Patient flowchart. Of 167 patients screened, 5 (3%) had negative RT-PCR results and chest CT findings compatible with 2019-nCoV pneumonia. Chart courtesy of Radiology

Feature | Computed Tomography (CT) | February 14, 2020 | By Melinda Taschetta-Millane
As the 2019-nCoV Pneumonia is taking the world by storm, researchers have found a possible way to predict this virus